HAPPY THANKSGIVING AND INVESTOR ALERT: The M&A Class Action Firm Continues to Investigate the Merger - EXAS, SEE, CDTX, and MRSN

28.11.25 05:11 Uhr

Werte in diesem Artikel

NEW YORK, Nov. 27, 2025/PRNewswire/ --

We wish you a Happy Thanksgiving and Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), who has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report, is investigating:

  • Exact Sciences Corporation (NASDAQ: EXAS) related to its sale to Abbott Laboratories. Under the terms of the proposed transaction, Exact Sciences shareholders are expected to receive $105.00 per common share. Is it a fair deal?

Click here for more info https://monteverdelaw.com/case/exact-sciences-corporation/.It is free and there is no cost or obligation to you.

  • Sealed Air Corp. (NYSE: SEE) related to its sale to Clayton, Dubilier & Rice, LLC. Under the terms of the proposed transaction, Sealed Air shareholders will receive $42.10 per share in cash. Is it a fair deal?

Click here for more info https://monteverdelaw.com/case/sealed-air-corp/.It is free and there is no cost or obligation to you.

  • Cidara Therapeutics, Inc. (NASDAQ: CDTX) related to its sale to Merck Sharp & Dohme LLC. Under the terms of the proposed transaction, Cidara shareholders will receive $221.50 per share in cash. Is it a fair deal?

Click here for more info https://monteverdelaw.com/case/cidara-therapeutics-inc/. It is free and there is no cost or obligation to you.

  • Mersana Therapeutics, Inc. (NASDAQ: MRSN) related to its sale to Day One Biopharmaceuticals, Inc. Under the terms of the proposed transaction, Mersana shareholders will receive $25.00 per share in cash plus one non-tradeable contingent value right ("CVR") per share to receive certain milestone payments of up to $30.25 per CVR in cash, for total consideration of up to $55.25 per share in cash. Is it a fair deal?

Click here for more info https://monteverdelaw.com/case/mersana-therapeutics-inc/.It is free and there is no cost or obligation to you.

Monteverde & Associates PC Logo

NOT ALL LAW FIRMS ARE THE SAME. Before you hire a law firm, you should talk to a lawyer and ask:

  • Do you file class actions and go to Court?
  • When was the last time you recovered money for shareholders?
  • What cases did you recover money in and how much?
  • About Monteverde & Associates PC

    Our firm litigates and has recovered money for shareholders…and we do it from our offices in the Empire State Building. We are a national class action securities firm with a successful track record in trial and appellate courts, including the U.S. Supreme Court. 

    No company, director or officer is above the law. If you own common stock in the above listed company and have concerns or wish to obtain additional information free of charge, please visit our website or contact Juan Monteverde, Esq. either via e-mail at jmonteverde@monteverdelaw.com or by telephone at (212) 971-1341.

    Contact:
    Juan Monteverde, Esq.
    MONTEVERDE & ASSOCIATES PC
    The Empire State Building
    350 Fifth Ave. Suite 4740
    New York, NY 10118
    United States of America
    jmonteverde@monteverdelaw.com
    Tel: (212) 971-1341

    Attorney Advertising. (C) 2025 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com).  Prior results do not guarantee a similar outcome with respect to any future matter.

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/happy-thanksgiving-and-investor-alert-the-ma-class-action-firm-continues-to-investigate-the-merger--exas-see-cdtx-and-mrsn-302627848.html

    SOURCE Monteverde & Associates PC

    In eigener Sache

    Übrigens: EXACT Sciences und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

    Ausgewählte Hebelprodukte auf Cidara Therapeutics

    Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Cidara Therapeutics

    NameHebelKOEmittent
    NameHebelKOEmittent
    Wer­bung

    Nachrichten zu EXACT Sciences Corp.

    Wer­bung

    Analysen zu EXACT Sciences Corp.

    DatumRatingAnalyst
    09.10.2018EXACT Sciences BuyUBS AG
    05.09.2018EXACT Sciences HoldThe Benchmark Company
    13.08.2018EXACT Sciences BuyCanaccord Adams
    03.04.2018EXACT Sciences BuyBTIG Research
    08.01.2018EXACT Sciences BuyThe Benchmark Company
    DatumRatingAnalyst
    09.10.2018EXACT Sciences BuyUBS AG
    13.08.2018EXACT Sciences BuyCanaccord Adams
    03.04.2018EXACT Sciences BuyBTIG Research
    08.01.2018EXACT Sciences BuyThe Benchmark Company
    31.10.2017EXACT Sciences BuyThe Benchmark Company
    DatumRatingAnalyst
    05.09.2018EXACT Sciences HoldThe Benchmark Company
    13.11.2017EXACT Sciences NeutralRobert W. Baird & Co. Incorporated
    01.11.2017EXACT Sciences NeutralBTIG Research
    26.07.2017EXACT Sciences HoldLake Street
    01.11.2016EXACT Sciences HoldLake Street
    DatumRatingAnalyst
    13.10.2014EXACT Sciences SellMaxim Group

    Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für EXACT Sciences Corp. nach folgenden Kriterien zu filtern.

    Alle: Alle Empfehlungen

    Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
    Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
    Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
    mehr Analysen